MedPath
HSA Approval

ESPIN CAPSULE 25 mg

SIN10607P

ESPIN CAPSULE 25 mg

ESPIN CAPSULE 25 mg

January 6, 1999

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N06AA16

dosulepin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

TAEJOON PHARM CO LTD

Active Ingredients

DOSULEPIN HCl

25 mg

Dosulepin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.